WallStreetZenWallStreetZen

NASDAQ: VYNE
Vyne Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Vyne Therapeutics earnings were -$42.2M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest VYNE earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$8.6M, down 28.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, VYNE reported annual earnings of -$39.8M, with 40% growth.

VYNE earnings history

Current Revenue
$605.0k
Current Earnings
-$42.2M
Current Profit Margin
-6,974.5%

VYNE Return on Equity

Current Company
-71.9%
Current Industry
-60.2%
Current Market
31.5%
VYNE's Return on Equity (-71.9%)... subscribe to Premium to read more.
High Return on Equity Performance

VYNE undefined

Current Company
-59%
Current Industry
-2.5%
VYNE is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when VYNE announces earnings.

VYNE undefined

Current Company
-95.6%
Current Industry
5.8%
VYNE's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

VYNE vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
VYNE-$42.18M-$42.20MN/A-$0.99
LYRA-$79.04M-$79.53MN/A-$60.50
MEIP-$29.66M-$31.66MN/A-$4.75
IBIO-$19.64M-$20.99MN/A-$0.31
SYBX$1.50M$1.50MN/A$0.12
View Top Biotech Stocks

Vyne Therapeutics Earnings Reports & History FAQ

What were Vyne Therapeutics's earnings last quarter?

On VYNE's earnings call on Invalid Date, Vyne Therapeutics (NASDAQ: VYNE) reported Q1 2025 earnings per share (EPS) of -$0.20, up 33.33% year over year. Total VYNE earnings for the quarter were -$8.61 million. In the same quarter last year, Vyne Therapeutics's earnings per share (EPS) was -$0.15.

If you're new to stock investing, here's how to buy Vyne Therapeutics stock.

Is Vyne Therapeutics profitable or losing money?

As of the last Vyne Therapeutics earnings report, Vyne Therapeutics is currently losing money. Vyne Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$42.20 million, a 45.11% increase year over year.

What was VYNE's earnings growth in the past year?

As of Vyne Therapeutics's earnings date in Invalid Date, Vyne Therapeutics's earnings has grown year over year. VYNE earnings in the past year totalled -$42.20 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.